Sapience Therapeutics

Sapience Therapeutics, Inc. is a biotechnology company focused on discovering and developing peptide-based therapeutics for the treatment of cancer and other serious diseases. They generate revenue through research collaborations, licensing agreements, and milestone payments from pharmaceutical partners. Founded in 2015, Sapience has made significant strides in targeting protein-protein interactions, which are crucial in disease progression. Their lead candidate, ST101, is currently in clinical trials, showcasing their commitment to innovative cancer therapies.

Recent Posts by Sapience Therapeutics

1-1 of 1